Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 86970 refers to the pretreatment of red blood cells (RBCs) specifically for the purposes of detecting, identifying, and/or testing compatibility for RBC antibodies. This procedure involves incubating the red blood cells with various chemical agents or drugs, which is crucial for analyzing the reaction that occurs. The primary goal of this process is to ascertain whether a specific drug is present in the bloodstream, particularly after a blood sample has tested positive for an antibody related to that drug. This testing is essential in transfusion medicine and helps ensure patient safety by identifying potential adverse reactions to transfused blood products. It is important to note that if the sample undergoes treatment with enzymes prior to examination, the appropriate code to use would be 86971. Additionally, if the components of the blood are separated before conducting the test, the correct code would be 86972. This structured approach to testing allows healthcare professionals to make informed decisions regarding patient care and treatment options.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 86970 is indicated in specific clinical scenarios where the detection of antibodies against red blood cells is necessary. The following conditions warrant the use of this procedure:
The procedure for CPT® Code 86970 involves several critical steps to ensure accurate results in the detection and identification of RBC antibodies. The following procedural steps are outlined:
Post-procedure care following the application of CPT® Code 86970 typically involves monitoring the patient for any immediate reactions, especially if the procedure is part of a transfusion process. The results of the antibody detection and compatibility testing will guide further clinical decisions, including whether to proceed with a blood transfusion or to consider alternative treatments. It is essential for healthcare providers to document the findings accurately and communicate any significant results to the patient and relevant medical staff to ensure safe and effective patient care.
| Short Descr | RBC PRETX INCUBATJ W/CHEMICL | Medium Descr | PRETX RBC ANTIBODY INCUBAT W/CHEM AGNTS/DRUGS EA | Long Descr | Pretreatment of RBCs for use in RBC antibody detection, identification, and/or compatibility testing; incubation with chemical agents or drugs, each | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | STV-Packaged Codes | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 235 - Other Laboratory |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2013-01-01 | Changed | Short Descriptor changed. |
| 1993-01-01 | Added | First appearance in code book in 1993. |
Get instant expert-level medical coding assistance.